Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2019-05-24 Board/Management Inform…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Tomas Blomquist blir ny VD och koncernchef för Biotage
Board/Management Information Classification · 100% confidence The document is titled "Pressmeddelande" (Press Release) and announces a significant change in senior management: 'Tomas Blomquist blir ny VD och koncernchef för Biotage' (Tomas Blomquist becomes the new CEO and Group President for Biotage). This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is short and serves as an immediate public announcement, not a comprehensive report.
2019-05-24 Swedish
Tomas Blomquist – new CEO & President of Biotage
Board/Management Information Classification · 100% confidence The document is a press release announcing a change in senior management: the appointment of Tomas Blomquist as the new CEO and President of Biotage AB, effective November 6, 2019. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is short and structured as a formal announcement, not a comprehensive financial report.
2019-05-24 English
Resolutions at the Annual General Meeting in Biotage AB on April 24, 2019
AGM Information Classification · 100% confidence The document is explicitly titled "Resolutions at the Annual General Meeting in Biotage AB on April 24, 2019". It details specific decisions made during this meeting, such as dividend appropriation, election/re-election of board members and auditors, fees, and authorizations. This content directly corresponds to the materials presented or resolved upon at an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information). The document is not a short announcement of a report (RPA/RNS), but the substance of the AGM resolutions themselves.
2019-04-24 English
Beslut vid årsstämman i Biotage AB den 24 april 2019
AGM Information Classification · 99% confidence The document is titled "Beslut vid årsstämman i Biotage AB den 24 april 2019" (Decisions at the Annual General Meeting of Biotage AB on April 24, 2019). It details specific resolutions passed at the meeting, including dividend approval, election/re-election of board members and auditors, approval of remuneration policies, and authorization for future share issues. These contents are characteristic of the formal documentation released following an Annual General Meeting (AGM). Since the document explicitly details the decisions made at the AGM, the most appropriate classification is AGM Information (AGM-R), rather than a general Regulatory Filing (RNS) or a Proxy Statement (PSI) which precedes the meeting.
2019-04-24 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-March 2019, published by Biotage AB. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it fits the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-04-24 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report' and covers the period 'January – March 2019'. It contains comprehensive financial statements, including net sales, operating profit, cash flow, balance sheet items, and management commentary on business performance. It is clearly a quarterly financial report, not an announcement of a report or a summary, and it contains substantive financial data. Q1 2019
2019-04-24 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.